{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:17:38Z","timestamp":1791893858032,"version":"4.3.4"},"reference-count":181,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Several theories regarding acute kidney injury (AKI)-related mortality have been entertained, although mounting evidence supports the paradigm that impaired kidney function directly and adversely affects the function of several remote organs. The kidneys and liver are fundamental to human metabolism and detoxification, and it is therefore hardly surprising that critical illness complicated by hepatorenal dysfunction portends a poor prognosis. Several diseases can simultaneously impact the proper functioning of the liver and kidneys, although this review will address the impact of AKI on liver function. While evidence for this relationship in humans remains sparse, we present supportive studies and then discuss the most likely mechanisms by which AKI can cause liver dysfunction. These include \u2018traditional\u2019 complications of AKI (uremia, volume overload and acute metabolic acidosis, among others) as well as systemic inflammation, hepatic leukocyte infiltration, cytokine-mediated liver injury and hepatic oxidative stress. We conclude by addressing the therapeutic implications of these findings to clinical medicine.<\/jats:p>","DOI":"10.1093\/ndt\/gfaa297","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T16:13:07Z","timestamp":1603815187000},"page":"1218-1228","source":"Crossref","is-referenced-by-count":27,"title":["Renohepatic crosstalk: a review of the effects of acute kidney injury on the liver"],"prefix":"10.1093","volume":"37","author":[{"given":"Anthony","family":"Bonavia","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Penn State Milton S. Hershey Medical Center , Hershey, PA, USA"},{"name":"Department of Pharmacology, Penn State College of Medicine , Hershey, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Stiles","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Penn State Milton S. Hershey Medical Center , Hershey, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"2022062300073919800_gfaa297-B1","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"key":"2022062300073919800_gfaa297-B2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.ajkd.2018.03.028","article-title":"Distant organ dysfunction in acute kidney injury: a review","volume":"72","author":"Lee","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2022062300073919800_gfaa297-B3","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.1996.03530430033035","article-title":"The effect of acute renal failure on mortality. A cohort analysis","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"key":"2022062300073919800_gfaa297-B4","first-page":"S16","article-title":"The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group","volume":"66","author":"Liano","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"2022062300073919800_gfaa297-B5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semnephrol.2005.09.003","article-title":"Acute renal failure: much more than a kidney disease","volume":"26","author":"Kelly","year":"2006","journal-title":"Semin Nephrol"},{"key":"2022062300073919800_gfaa297-B6","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/01.ASN.0000014692.19351.52","article-title":"Refining predictive models in critically ill patients with acute renal failure","volume":"13","author":"Mehta","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2022062300073919800_gfaa297-B7","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/ndt\/gft091","article-title":"Renohepatic crosstalk: does acute kidney injury cause liver dysfunction?","volume":"28","author":"Lane","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2022062300073919800_gfaa297-B8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1055\/s-0038-1673616","article-title":"Kidney injury and electrolyte abnormalities in liver failure","volume":"39","author":"Bonavia","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"2022062300073919800_gfaa297-B9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/kisup.2012.7","article-title":"Summary of recommendation statements","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"key":"2022062300073919800_gfaa297-B10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: current understanding, key questions, and knowledge gaps","volume":"27","author":"Rabb","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2022062300073919800_gfaa297-B11","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00467-017-3774-5","article-title":"A review of the role of immune cells in acute kidney injury","volume":"33","author":"Bonavia","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"2022062300073919800_gfaa297-B12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccc.2015.06.010","article-title":"Short-term effects of acute kidney injury","volume":"31","author":"Singbartl","year":"2015","journal-title":"Crit Care Clin"},{"key":"2022062300073919800_gfaa297-B13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/ALN.0b013e31824f951b","article-title":"Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence","volume":"116","author":"Yap","year":"2012","journal-title":"Anesthesiology"},{"key":"2022062300073919800_gfaa297-B14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","article-title":"IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia\u2013the good, the bad, and the ugly","volume":"67","author":"Stenvinkel","year":"2005","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B15","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/00003246-200209000-00016","article-title":"Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients","volume":"30","author":"Metnitz","year":"2002","journal-title":"Crit Care Med"},{"key":"2022062300073919800_gfaa297-B16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMoa0802639","article-title":"Intensity of renal support in critically ill patients with acute kidney injury","volume":"359","author":"Network","year":"2008","journal-title":"N Engl J Med"},{"key":"2022062300073919800_gfaa297-B17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000218087","article-title":"Kidney-lung crosstalk in the critically ill patient","volume":"28","author":"Ko","year":"2009","journal-title":"Blood Purif"},{"key":"2022062300073919800_gfaa297-B18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jama.1950.02920100007003","article-title":"Pulmonary changes in uremia","volume":"144","author":"Bass","year":"1950","journal-title":"JAMA"},{"key":"2022062300073919800_gfaa297-B19","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1046\/j.1523-1755.1999.00460.x","article-title":"Renal ischemia\/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability","volume":"55","author":"Kramer","year":"1999","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B20","doi-asserted-by":"crossref","first-page":"F30","DOI":"10.1152\/ajprenal.00023.2007","article-title":"Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy","volume":"293","author":"Hassoun","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022062300073919800_gfaa297-B21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MCC.0b013e328334b13b","article-title":"Pulmonary\/renal interaction","volume":"16","author":"Ricci","year":"2010","journal-title":"Curr Opin Crit Care"},{"key":"2022062300073919800_gfaa297-B22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00134-019-05869-7","article-title":"Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup","volume":"46","author":"Joannidis","year":"2020","journal-title":"Intensive Care Med"},{"key":"2022062300073919800_gfaa297-B23","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/archinte.1995.00430140075007","article-title":"Prognostic stratification in critically ill patients with acute renal failure requiring dialysis","volume":"155","author":"Chertow","year":"1995","journal-title":"Arch Intern Med"},{"key":"2022062300073919800_gfaa297-B24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ki.2008.683","article-title":"Ischemic and non-ischemic acute kidney injury cause hepatic damage","volume":"75","author":"Golab","year":"2009","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.taap.2018.10.022","article-title":"PPAR gamma agonist, pioglitazone, rescues liver damage induced by renal ischemia\/reperfusion injury","volume":"362","author":"Elshazly","year":"2019","journal-title":"Toxicol Appl Pharm"},{"key":"2022062300073919800_gfaa297-B26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/jsre.2002.6513","article-title":"Changes in hepatic TNF-alpha levels, antioxidant status, and oxidation products after renal ischemia\/reperfusion injury in mice","volume":"107","author":"Serteser","year":"2002","journal-title":"J Surg Res"},{"key":"2022062300073919800_gfaa297-B27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1067\/mlc.2002.122832","article-title":"Leukocyte accumulation and changes in extra-renal organs during renal ischemia reperfusion in mice","volume":"139","author":"Miyazawa","year":"2002","journal-title":"J Lab Clin Med"},{"key":"2022062300073919800_gfaa297-B28","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1016\/j.transproceed.2010.09.008","article-title":"Liver injury following renal ischemia reperfusion in rats","volume":"42","author":"Wang","year":"2010","journal-title":"Transplant Proc"},{"key":"2022062300073919800_gfaa297-B29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/labinvest.2010.151","article-title":"Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy","volume":"91","author":"Park","year":"2011","journal-title":"Lab Invest"},{"key":"2022062300073919800_gfaa297-B30","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1172\/JCI39421","article-title":"Animal models of sepsis and sepsis-induced kidney injury","volume":"119","author":"Doi","year":"2009","journal-title":"J Clin Invest"},{"key":"2022062300073919800_gfaa297-B31","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J Immunol"},{"key":"2022062300073919800_gfaa297-B32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.RES.37.5.558","article-title":"Pathogenesis of acute renal failure following temporary renal ischemia in the rat","volume":"37","author":"Arendshorst","year":"1975","journal-title":"Circ Res"},{"key":"2022062300073919800_gfaa297-B33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11255-013-0520-1","article-title":"Unilateral ureteral obstruction: beyond obstruction","volume":"46","author":"Ucero","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"2022062300073919800_gfaa297-B34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5527\/wjn.v5.i2.139","article-title":"Major comorbid disease processes associated with increased incidence of acute kidney injury","volume":"5","author":"Farooqi","year":"2016","journal-title":"World J Nephrol"},{"key":"2022062300073919800_gfaa297-B35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1242\/dmm.024547","article-title":"Using the mouse to model human disease: increasing validity and reproducibility","volume":"9","author":"Justice","year":"2016","journal-title":"Dis Model Mech"},{"key":"2022062300073919800_gfaa297-B36","doi-asserted-by":"crossref","first-page":"F259","DOI":"10.1152\/ajprenal.00389.2015","article-title":"Remote effects of acute kidney injury in a porcine model","volume":"310","author":"Gardner","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022062300073919800_gfaa297-B37","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.2000.278.1.F1","article-title":"Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable","volume":"278","author":"Lieberthal","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022062300073919800_gfaa297-B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/532127","article-title":"Contribution of large pig for renal ischemia-reperfusion and transplantation studies: the preclinical model","volume":"2011","author":"Giraud","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"2022062300073919800_gfaa297-B39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.ackd.2016.02.007","article-title":"Immediate consequences of acute kidney injury: the impact of traditional and nontraditional complications on mortality in acute kidney injury","volume":"23","author":"Faubel","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"2022062300073919800_gfaa297-B40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semnephrol.2018.10.001","article-title":"Pulmonary consequences of acute kidney injury","volume":"39","author":"Teixeira","year":"2019","journal-title":"Semin Nephrol"},{"key":"2022062300073919800_gfaa297-B41","first-page":"F257","article-title":"Extrarenal potassium homeostasis","volume":"240","author":"Bia","year":"1981","journal-title":"Am J Physiol"},{"key":"2022062300073919800_gfaa297-B42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.ackd.2008.04.008","article-title":"Pulmonary complications after acute kidney injury","volume":"15","author":"Faubel","year":"2008","journal-title":"Adv Chronic Kidney Dis"},{"key":"2022062300073919800_gfaa297-B43","first-page":"783","article-title":"Hepatobiliary pathology in hemodialysis patients: an autopsy study of 78 cases","volume":"81","author":"Pahl","year":"1986","journal-title":"Am J Gastroenterol"},{"key":"2022062300073919800_gfaa297-B44","first-page":"23","article-title":"Hepatic changes during short-term haemodialysis","volume":"40","author":"Rai","year":"1992","journal-title":"J Assoc Physicians India"},{"key":"2022062300073919800_gfaa297-B45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ackd.2012.10.005","article-title":"Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes","volume":"20","author":"Cruz","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"2022062300073919800_gfaa297-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/148082","article-title":"Advances in the pathogenesis of cardiorenal syndrome type 3","volume":"2015","author":"Clementi","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"2022062300073919800_gfaa297-B47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000441-197303000-00001","article-title":"The liver in congestive heart failure: a review","volume":"265","author":"Dunn","year":"1973","journal-title":"Am J Med Sci"},{"key":"2022062300073919800_gfaa297-B48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4254\/wjh.v6.i1.41","article-title":"Hepato-cardiac disorders","volume":"6","author":"Fouad","year":"2014","journal-title":"World J Hepatol"},{"key":"2022062300073919800_gfaa297-B49","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ki.2013.399","article-title":"Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport","volume":"85","author":"Yeung","year":"2014","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B50","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/BF01711224","article-title":"Clearance of ceftriaxone in critical care patients with acute renal failure","volume":"16","author":"Heinemeyer","year":"1990","journal-title":"Intensive Care Med"},{"key":"2022062300073919800_gfaa297-B51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/bdd.409","article-title":"Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate","volume":"25","author":"Lee","year":"2004","journal-title":"Biopharm Drug Dispos"},{"key":"2022062300073919800_gfaa297-B52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1248\/bpb.27.384","article-title":"Evaluation of factors to decrease bioavailability of cyclosporin A in rats with gentamicin-induced acute renal failure","volume":"27","author":"Shibata","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"2022062300073919800_gfaa297-B53","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1023\/A:1015868525978","article-title":"Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure","volume":"09","author":"Lee","year":"1992","journal-title":"Pharm Res"},{"key":"2022062300073919800_gfaa297-B54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02975102","article-title":"Pharmacokinetics of diltiazem and its major metabolite, deacetyidiltiazem after oral administration of diltiazem in mild and medium folate-induced renal failure rabbits","volume":"24","author":"Choi","year":"2001","journal-title":"Arch Pharm Res"},{"key":"2022062300073919800_gfaa297-B55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF03191003","article-title":"Pharmacokinetics of etoposide in rats with uranyl nitrate (UN)-induced acute renal failure (ARF): optimization of the duration of UN dosing","volume":"32","author":"Venkatesh","year":"2007","journal-title":"Eur J Drug Metabol Pharmacokinet"},{"key":"2022062300073919800_gfaa297-B56","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1248\/bpb.25.1077","article-title":"Effect of experimental renal failure on the pharmacokinetics of losartan in rats","volume":"25","author":"Yoshitani","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"2022062300073919800_gfaa297-B57","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1248\/bpb.27.1422","article-title":"Intestinal absorption and hepatic extraction of propranolol and metoprolol in rats with bilateral ureteral ligation","volume":"27","author":"Okabe","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"2022062300073919800_gfaa297-B58","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1248\/bpb.30.552","article-title":"Pharmacokinetics and hepatic extraction of metoprolol in rats with glycerol-induced acute renal failure","volume":"30","author":"Tanabe","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"2022062300073919800_gfaa297-B59","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00315516","article-title":"The kinetics of metamizol and its metabolites in critical-care patients with acute renal dysfunction","volume":"45","author":"Heinemeyer","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"2022062300073919800_gfaa297-B60","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00134-011-2360-8","article-title":"Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients","volume":"38","author":"Kirwan","year":"2012","journal-title":"Intensive Care Med"},{"key":"2022062300073919800_gfaa297-B61","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1211\/002235702982","article-title":"The increased intestinal absorption rate is responsible for the reduced hepatic first-pass extraction of propranolol in rats with cisplatin-induced renal dysfunction","volume":"55","author":"Okabe","year":"2003","journal-title":"J Pharm Pharmacol"},{"key":"2022062300073919800_gfaa297-B62","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1023\/A:1026131216669","article-title":"The hepatic and intestinal metabolic activities of P450 in rats with surgery- and drug-induced renal dysfunction","volume":"20","author":"Okabe","year":"2003","journal-title":"Pharm Res"},{"key":"2022062300073919800_gfaa297-B63","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2133\/dmpk.24.451","article-title":"Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure","volume":"24","author":"Izuwa","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"2022062300073919800_gfaa297-B64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1211\/0022357021771931","article-title":"Evaluation of increased bioavailability of tacrolimus in rats with experimental renal dysfunction","volume":"54","author":"Okabe","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"2022062300073919800_gfaa297-B65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/bdd.542","article-title":"Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin","volume":"28","author":"Lee","year":"2007","journal-title":"Biopharm Drug Dispos"},{"key":"2022062300073919800_gfaa297-B66","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1211\/002235702333","article-title":"Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation","volume":"54","author":"Yu","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"2022062300073919800_gfaa297-B67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2133\/dmpk.DMPK-09-LE-101","article-title":"Pharmacokinetics of tolbutamide in acute renal failure induced by glycerol: speculative thoughts and perspectives","volume":"26","author":"Srinivas","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"key":"2022062300073919800_gfaa297-B68","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00134-014-3372-y","article-title":"Using tramadol to measure CYP2D6 metabolism in critically ill adults","volume":"40","author":"Lane","year":"2014","journal-title":"Intensive Care Med"},{"key":"2022062300073919800_gfaa297-B69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome p450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"2022062300073919800_gfaa297-B70","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1053\/ajkd.2003.50101","article-title":"Liver metabolism in CRF","volume":"41","author":"Smogorzewski","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2022062300073919800_gfaa297-B71","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/106002809102501111","article-title":"The effect of renal failure on hepatic drug clearance","volume":"25","author":"Touchette","year":"1991","journal-title":"DICP"},{"key":"2022062300073919800_gfaa297-B72","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/bja\/71.2.282","article-title":"Effect of renal failure on drug metabolism by the liver","volume":"71","author":"Elston","year":"1993","journal-title":"Br J Anaesth"},{"key":"2022062300073919800_gfaa297-B73","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/clpt.2009.163","article-title":"The influence of chronic renal failure on drug metabolism and transport","volume":"86","author":"Dreisbach","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"2022062300073919800_gfaa297-B74","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1681\/ASN.V122326","article-title":"Downregulation of hepatic cytochrome P450 in chronic renal failure","volume":"12","author":"Leblond","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2022062300073919800_gfaa297-B75","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.bjp.0706138","article-title":"Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450","volume":"144","author":"Michaud","year":"2005","journal-title":"Br J Pharmacol"},{"key":"2022062300073919800_gfaa297-B76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.05.010","article-title":"Effects of renal failure on drug transport and metabolism","volume":"109","author":"Sun","year":"2006","journal-title":"Pharmacol Ther"},{"key":"2022062300073919800_gfaa297-B77","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/clpt.2008.59","article-title":"Emerging evidence of the impact of kidney disease on drug metabolism and transport","volume":"83","author":"Nolin","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"2022062300073919800_gfaa297-B78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.109.853069","article-title":"New P2Y(12) inhibitors","volume":"121","author":"Cattaneo","year":"2010","journal-title":"Circulation"},{"key":"2022062300073919800_gfaa297-B79","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022062300073919800_gfaa297-B80","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1538-7836.2011.04602.x","article-title":"Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?","volume":"10","author":"Cattaneo","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2022062300073919800_gfaa297-B81","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00044011-199816040-00006","article-title":"Clopidogrel activities in patients with renal function impairment","volume":"16","author":"Deray","year":"1998","journal-title":"Clin Drug Investig"},{"key":"2022062300073919800_gfaa297-B82","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11239-012-0828-1","article-title":"Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus","volume":"36","author":"Tello-Montoliu","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"2022062300073919800_gfaa297-B83","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.amjcard.2015.11.029","article-title":"Differences in whole blood platelet aggregation at baseline and in response to aspirin and aspirin plus clopidogrel in patients with versus without chronic kidney disease","volume":"117","author":"Jain","year":"2016","journal-title":"Am J Cardiol"},{"key":"2022062300073919800_gfaa297-B84","doi-asserted-by":"crossref","first-page":"e28099","DOI":"10.5812\/numonthly.28099","article-title":"Antiplatelet therapy in hemodialysis patients undergoing percutaneous coronary interventions","volume":"7","author":"Summaria","year":"2015","journal-title":"Nephrourol Mon"},{"key":"2022062300073919800_gfaa297-B85","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1046\/j.1523-1755.2002.00279.x","article-title":"Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency","volume":"61","author":"Haubitz","year":"2002","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B86","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00280-008-0757-z","article-title":"Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency","volume":"63","author":"Ekhart","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"2022062300073919800_gfaa297-B87","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/1389200220666190402143125","article-title":"Decreased disposition of anticancer drugs predominantly eliminated via the liver in patients with renal failure","volume":"20","author":"Fujita","year":"2019","journal-title":"Curr Durg Metab"},{"key":"2022062300073919800_gfaa297-B88","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2007.04.011","article-title":"Pegylated liposomal doxorubicin treatment in recurrent gynecologic cancer patients with renal dysfunction","volume":"106","author":"Li","year":"2007","journal-title":"Gynecol Oncol"},{"key":"2022062300073919800_gfaa297-B89","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00280-015-2878-5","article-title":"Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function","volume":"76","author":"Tan","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"2022062300073919800_gfaa297-B90","first-page":"1300","article-title":"Disposition of [G-(3)H]paclitaxel and cremophor EL in a patient with severely impaired renal function","volume":"27","author":"Gelderblom","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"2022062300073919800_gfaa297-B91","doi-asserted-by":"crossref","first-page":"91s","DOI":"10.1177\/0091270011415528","article-title":"Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation","volume":"52","author":"Zhao","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"2022062300073919800_gfaa297-B92","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/cpt.1205","article-title":"Use of physiologically based pharmacokinetic modeling to evaluate the effect of chronic kidney disease on the disposition of hepatic CYP2C8 and OATP1B drug substrates","volume":"105","author":"Tan","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2022062300073919800_gfaa297-B93","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI105186","article-title":"N15 tracer studies on the origin of urinary ammonia in the acidotic dog, with notes on the enzymatic synthesis of labeled clutamic acid and glutamines","volume":"44","author":"Pitts","year":"1965","journal-title":"J Clin Invest"},{"key":"2022062300073919800_gfaa297-B94","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/B978-1-4160-4252-5.50200-8","volume-title":"Critical Care Nephrology","author":"Bourke","year":"2009"},{"key":"2022062300073919800_gfaa297-B95","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000421452","article-title":"pH homeostasis: the conceptual change","volume":"100","author":"Bourke","year":"1992","journal-title":"Contrib Nephrol"},{"key":"2022062300073919800_gfaa297-B96","doi-asserted-by":"crossref","first-page":"2068S","DOI":"10.1093\/jn\/133.6.2068S","article-title":"Interorgan amino acid transport and its regulation","volume":"133","author":"Brosnan","year":"2003","journal-title":"J Nutr"},{"key":"2022062300073919800_gfaa297-B97","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ki.1982.44","article-title":"Effects of acute metabolic acidosis on renal, gut, liver, and muscle metabolism of glutamine and ammonia in the dog","volume":"21","author":"Fine","year":"1982","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/bj2020271","article-title":"The effects of chronic metabolic acidosis on liver and muscle glutamine metabolism in the dog in vivo","volume":"202","author":"Fine","year":"1982","journal-title":"Biochem J"},{"key":"2022062300073919800_gfaa297-B99","first-page":"E735","article-title":"Ammonium chloride-induced acidosis increases protein breakdown and amino acid oxidation in humans","volume":"263","author":"Reaich","year":"1992","journal-title":"Am J Physiol"},{"key":"2022062300073919800_gfaa297-B100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0261-5614(03)00041-4","article-title":"Effect of acute acidosis on protein and amino acid metabolism in rats","volume":"22","author":"\u0160afr\u00e1nek","year":"2003","journal-title":"Clin Nutr"},{"key":"2022062300073919800_gfaa297-B101","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1053\/ajkd.2001.29215","article-title":"Acute metabolic acidosis decreases muscle protein synthesis but not albumin synthesis in humans","volume":"38","author":"Kleger","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2022062300073919800_gfaa297-B102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2613.2003.00352.x","article-title":"Acute effects of acidosis on protein and amino acid metabolism in perfused rat liver","volume":"84","author":"Holecek","year":"2003","journal-title":"Int J Exp Pathol"},{"key":"2022062300073919800_gfaa297-B103","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1172\/JCI117668","article-title":"Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans","volume":"95","author":"Ballmer","year":"1995","journal-title":"J Clin Invest"},{"key":"2022062300073919800_gfaa297-B104","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/ki.1978.88","article-title":"Relation of ammonia excretion adaptation to glutaminase activity in acidotic, subtotalnephrectomized rats","volume":"14","author":"Benyajati","year":"1978","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B105","first-page":"347","article-title":"Renal gluconeogenesis","volume":"14","author":"Schoolwerth","year":"1988","journal-title":"Miner Electrolyte Metab"},{"key":"2022062300073919800_gfaa297-B106","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ki.1984.143","article-title":"Enzyme distribution along the nephron","volume":"26","author":"Guder","year":"1984","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B107","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/diacare.24.2.382","article-title":"Renal gluconeogenesis: its importance in human glucose homeostasis","volume":"24","author":"Gerich","year":"2001","journal-title":"Diabetes Care"},{"key":"2022062300073919800_gfaa297-B108","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1523-1755.1999.055003778.x","article-title":"Role of glutamine in human carbohydrate metabolism in kidney and other tissues","volume":"55","author":"Stumvoll","year":"1999","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B109","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/ki.2010.509","article-title":"Glucose handling by the kidney","volume":"79","author":"Mather","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"2022062300073919800_gfaa297-B110","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1172\/JCI106016","article-title":"Liver and kidney metabolism during prolonged starvation","volume":"48","author":"Owen","year":"1969","journal-title":"J Clin Invest"},{"key":"2022062300073919800_gfaa297-B111","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0889-8529(18)30391-8","article-title":"Hypoglycemia associated with renal failure","volume":"18","author":"Arem","year":"1989","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2022062300073919800_gfaa297-B112","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1093\/ndt\/13.12.2996","article-title":"Glucose production by the human kidney\u2013its importance has been underestimated","volume":"13","author":"Stumvoll","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"2022062300073919800_gfaa297-B113","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s42255-020-0238-1","article-title":"Altered proximal tubular cell glucose metabolism during acute kidney injury is associated with mortality","volume":"2","author":"Legouis","year":"2020","journal-title":"Nat Metab"},{"key":"2022062300073919800_gfaa297-B114","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1681\/ASN.2013070791","article-title":"Renal cortical pyruvate depletion during AKI","volume":"25","author":"Zager","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2022062300073919800_gfaa297-B115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem J"},{"key":"2022062300073919800_gfaa297-B116","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MCC.0b013e328332f69e","article-title":"Organ crosstalk: the role of the kidney","volume":"15","author":"Li","year":"2009","journal-title":"Curr Opin Crit Care"},{"key":"2022062300073919800_gfaa297-B117","first-page":"189:","article-title":"Paneth cell-mediated multiorgan dysfunction after acute kidney injury","author":"Park","year":"2012","journal-title":"J Immunol"},{"key":"2022062300073919800_gfaa297-B118","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/315275","article-title":"Interleukin 10 inhibits the release of CC chemokines during human endotoxemia","volume":"181","author":"Olszyna","year":"2000","journal-title":"J Infect Dis"},{"key":"2022062300073919800_gfaa297-B119","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5500\/wjt.v3.i4.91","article-title":"Role of IL-10 in the progression of kidney disease","volume":"3","author":"Sinuani","year":"2013","journal-title":"World J Transplant"},{"key":"2022062300073919800_gfaa297-B120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000345146","article-title":"Uremia suppresses immune signal-induced CYP27B1 expression in human monocytes","volume":"36","author":"Viaene","year":"2012","journal-title":"Am J Nephrol"},{"key":"2022062300073919800_gfaa297-B121","doi-asserted-by":"crossref","first-page":"e016486","DOI":"10.1136\/bmjopen-2017-016486","article-title":"Vitamin D levels in critically ill patients with acute kidney injury: a protocol for a prospective cohort study (VID-AKI)","volume":"7","author":"Cameron","year":"2017","journal-title":"BMJ Open"},{"key":"2022062300073919800_gfaa297-B122","doi-asserted-by":"crossref","first-page":"14177","DOI":"10.1074\/jbc.M408587200","article-title":"Calcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1beta. Role of the NF-kappaB PATHWAY and kappaB elements","volume":"280","author":"Canaff","year":"2005","journal-title":"J Biol Chem"},{"key":"2022062300073919800_gfaa297-B123","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semnephrol.2018.10.004","article-title":"Dysregulated mineral metabolism in AKI","volume":"39","author":"Leaf","year":"2019","journal-title":"Semin Nephrol"},{"key":"2022062300073919800_gfaa297-B124","doi-asserted-by":"crossref","first-page":"e0191290","DOI":"10.1371\/journal.pone.0191290","article-title":"Phosphate is a potential biomarker of disease severity and predicts adverse outcomes in acute kidney injury patients undergoing continuous renal replacement therapy","volume":"13","author":"Jung","year":"2018","journal-title":"PLoS One"},{"key":"2022062300073919800_gfaa297-B125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2110-5820-1-21","article-title":"FGF-23 and PTH levels in patients with acute kidney injury: a cross-sectional case series study","volume":"1","author":"Zhang","year":"2011","journal-title":"Ann Intensive Care"},{"key":"2022062300073919800_gfaa297-B126","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2215\/CJN.00550112","article-title":"FGF-23 levels in patients with AKI and risk of adverse outcomes","volume":"7","author":"Leaf","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022062300073919800_gfaa297-B127","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jbmr.1740","article-title":"Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes","volume":"28","author":"Bacchetta","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2022062300073919800_gfaa297-B129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semnephrol.2018.10.005","article-title":"Fibroblast growth factor 23 and klotho in AKI","volume":"39","author":"Christov","year":"2019","journal-title":"Semin Nephrol"},{"key":"2022062300073919800_gfaa297-B130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2022062300073919800_gfaa297-B131","doi-asserted-by":"crossref","first-page":"10545","DOI":"10.3748\/wjg.v22.i48.10545","article-title":"Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis","volume":"22","author":"Segarra","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2022062300073919800_gfaa297-B132","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3892\/mmr.2015.3619","article-title":"Role of asymmetric dimethylarginine in rat acute lung injury induced by acute ischemic kidney injury","volume":"12","author":"Ma","year":"2015","journal-title":"Mol Med Rep"},{"key":"2022062300073919800_gfaa297-B133","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/17425255.2013.835802","article-title":"The effects of acute renal failure on drug metabolism","volume":"10","author":"Philips","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2022062300073919800_gfaa297-B134","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12882-019-1238-9","article-title":"Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study","volume":"20","author":"Wang","year":"2019","journal-title":"BMC Nephrol"},{"key":"2022062300073919800_gfaa297-B135","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2022062300073919800_gfaa297-B136","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1211\/jpp.62.01.0015","article-title":"Inhibitory effects of uraemic toxins 3-indoxyl sulfate and p-cresol on losartan metabolism in vitro","volume":"62","author":"Tsujimoto","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"2022062300073919800_gfaa297-B137","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.ki.5000340","article-title":"Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells","volume":"69","author":"Yamamoto","year":"2006","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B138","doi-asserted-by":"crossref","first-page":"38869","DOI":"10.1074\/jbc.M110.166686","article-title":"Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin","volume":"285","author":"Ito","year":"2010","journal-title":"J Biol Chem"},{"key":"2022062300073919800_gfaa297-B139","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfl584","article-title":"P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production","volume":"22","author":"Schepers","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"2022062300073919800_gfaa297-B140","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B141","first-page":"1867","article-title":"Bioactivation of 4-methylphenol (p-cresol) via cytochrome p450-mediated aromatic oxidation in human liver microsomes","volume":"33","author":"Yan","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"2022062300073919800_gfaa297-B142","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/healthcare7010010","article-title":"Acute kidney injury pharmacokinetic changes and its impact on drug prescription","volume":"7","author":"Blanco","year":"2019","journal-title":"Healthcare (Basel)"},{"key":"2022062300073919800_gfaa297-B143","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.1989.tb24001.x","article-title":"Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat","volume":"557","author":"Castell","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"2022062300073919800_gfaa297-B144","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1523-1755.2004.00512.x","article-title":"Plasma cytokine levels predict mortality in patients with acute renal failure","volume":"65","author":"Simmons","year":"2004","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B145","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s12272-001-1216-3","article-title":"Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus","volume":"31","author":"Fadillioglu","year":"2008","journal-title":"Arch Pharm Res"},{"key":"2022062300073919800_gfaa297-B146","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12882-019-1265-6","article-title":"Association between serum levels of interleukin-6 on ICU admission and subsequent outcomes in critically ill patients with acute kidney injury","volume":"20","author":"Shimazui","year":"2019","journal-title":"BMC Nephrol"},{"key":"2022062300073919800_gfaa297-B147","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.107.018747","article-title":"Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer","volume":"36","author":"Morgan","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"2022062300073919800_gfaa297-B148","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.1840220420","article-title":"Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture","volume":"22 (4 Pt 1","author":"Muntane-Relat","year":"1995","journal-title":"Hepatology"},{"key":"2022062300073919800_gfaa297-B149","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1006\/bbrc.2000.3219","article-title":"Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes","volume":"274","author":"Pascussi","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2022062300073919800_gfaa297-B150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1012007517877","article-title":"Extrahepatic ischemia-reperfusion injury reduces hepatic oxidative drug metabolism as determined by serial antipyrine clearance","volume":"14","author":"Gurley","year":"1997","journal-title":"Pharm Res"},{"key":"2022062300073919800_gfaa297-B151","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1124\/dmd.30.6.739","article-title":"Increase in urea in conjunction with L-arginine metabolism in the liver leads to induction of cytochrome P450 2E1 (CYP2E1): the role of urea in CYP2E1 induction by acute renal failure","volume":"30","author":"Chung","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"2022062300073919800_gfaa297-B152","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1211\/jpp.61.10.0008","article-title":"Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1\/2","volume":"61","author":"Choi","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"2022062300073919800_gfaa297-B153","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.etp.2008.12.010","article-title":"Hepatotoxicity and gene expression down-regulation of CYP isozymes caused by renal ischemia\/reperfusion in the rat","volume":"61","author":"Wang","year":"2009","journal-title":"Exp Toxicol Pathol"},{"key":"2022062300073919800_gfaa297-B154","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.2042-7158.2011.01303.x","article-title":"Effect of thymoquinone on hepatorenal dysfunction and alteration of CYP3A1 and spermidine\/spermine N-1-acetyl-transferase gene expression induced by renal ischaemia-reperfusion in rats","volume":"63","author":"Awad","year":"2011","journal-title":"J Pharm Pharmacol"},{"key":"2022062300073919800_gfaa297-B155","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1124\/dmd.111.038679","article-title":"Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture","volume":"39","author":"Dickmann","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"2022062300073919800_gfaa297-B156","first-page":"534","article-title":"Liver oxidative stress after renal ischemia-reperfusion injury is leukocyte dependent in inbred mice","volume":"14","author":"Khastar","year":"2011","journal-title":"Iran J Basic Med Sci"},{"key":"2022062300073919800_gfaa297-B157","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3109\/0886022X.2015.1006084","article-title":"Protective effects of vitamin E against liver damage caused by renal ischemia reperfusion","volume":"37","author":"Khastar","year":"2015","journal-title":"Ren Fail"},{"key":"2022062300073919800_gfaa297-B158","first-page":"1","article-title":"Catalytic properties and immobilization studies of catalase from Malva sylvestris L","volume":"2013","author":"Arabaci","year":"2013","journal-title":"J Chem N Y"},{"key":"2022062300073919800_gfaa297-B159","doi-asserted-by":"crossref","first-page":"e0188270","DOI":"10.1371\/journal.pone.0188270","article-title":"Protective effect of Malva sylvestris L. extract in ischemia-reperfusion induced acute kidney and remote liver injury","volume":"12","author":"Najafi","year":"2017","journal-title":"Plos One"},{"key":"2022062300073919800_gfaa297-B160","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.biopha.2018.07.115","article-title":"Reduction of cisplatin-induced renal and hepatic side effects in rat through antioxidative and anti-inflammatory properties of Malva sylvestris L. extract","volume":"106","author":"Yarijani","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"2022062300073919800_gfaa297-B161","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1179\/135100004225004742","article-title":"Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress","volume":"9","author":"Vijayakumar","year":"2004","journal-title":"Redox Rep"},{"key":"2022062300073919800_gfaa297-B162","doi-asserted-by":"crossref","first-page":"e02180","DOI":"10.1016\/j.heliyon.2019.e02180","article-title":"Piperine pretreatment attenuates renal ischemia-reperfusion induced liver injury","volume":"5","author":"Mohammadi","year":"2019","journal-title":"Heliyon"},{"key":"2022062300073919800_gfaa297-B163","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jss.2012.08.020","article-title":"The effects of PPAR-gamma agonist pioglitazone on renal ischemia\/reperfusion injury in rats","volume":"182","author":"Reel","year":"2013","journal-title":"J Surg Res"},{"key":"2022062300073919800_gfaa297-B164","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jss.2013.03.027","article-title":"Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity","volume":"184","author":"Zou","year":"2013","journal-title":"J Surg Res"},{"key":"2022062300073919800_gfaa297-B165","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-2007-1007252","article-title":"Bacterial and fungal infection in acute liver failure","volume":"16","author":"Rolando","year":"1996","journal-title":"Semin Liver Dis"},{"key":"2022062300073919800_gfaa297-B166","doi-asserted-by":"crossref","first-page":"16795","DOI":"10.3748\/wjg.v20.i45.16795","article-title":"Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis","volume":"20","author":"Giannelli","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2022062300073919800_gfaa297-B167","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10620-019-05943-6","article-title":"Bacterial infection in patients with cirrhosis: don't get bugged to death","volume":"65","author":"Cannon","year":"2020","journal-title":"Dig Dis Sci"},{"key":"2022062300073919800_gfaa297-B168","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00134-014-3349-x","article-title":"Understanding infection susceptibility in patients with acute-on-chronic liver failure","volume":"40","author":"Selvapatt","year":"2014","journal-title":"Intensive Care Med"},{"key":"2022062300073919800_gfaa297-B169","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000063556","article-title":"Incidence of infectious morbidity and mortality in dialysis patients","volume":"20","author":"Vanholder","year":"2002","journal-title":"Blood Purif"},{"key":"2022062300073919800_gfaa297-B170","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/TA.0b013e31828586ec","article-title":"Acute kidney injury is associated with early cytokine changes after trauma","volume":"74","author":"Bihorac","year":"2013","journal-title":"J Trauma Acute Care"},{"key":"2022062300073919800_gfaa297-B171","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1492-7535.2003.00029.x","article-title":"Predicting acute renal failure after cardiac surgery: validation and re-definition of a risk-stratification algorithm","volume":"7","author":"Thakar","year":"2003","journal-title":"Hemodial Int"},{"key":"2022062300073919800_gfaa297-B172","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2215\/CJN.04560514","article-title":"Associations between intensity of RRT, inflammatory mediators, and outcomes","volume":"10","author":"Murugan","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022062300073919800_gfaa297-B173","doi-asserted-by":"crossref","first-page":"F546","DOI":"10.1152\/ajprenal.00072.2006","article-title":"Acute renal failure: determinants and characteristics of the injury-induced hyperinflammatory response","volume":"291","author":"Zager","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022062300073919800_gfaa297-B174","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1093\/ndt\/gfs256","article-title":"Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy","volume":"27","author":"Andres-Hernando","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2022062300073919800_gfaa297-B175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/ki.2011.125","article-title":"Acute loss of renal function attenuates slow leukocyte rolling and transmigration by interfering with intracellular signaling","volume":"80","author":"Rossaint","year":"2011","journal-title":"Kidney Int"},{"key":"2022062300073919800_gfaa297-B176","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"2022062300073919800_gfaa297-B177","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3182070c3a","article-title":"Isoflurane activates intestinal sphingosine kinase to protect against renal ischemia-reperfusion-induced liver and intestine injury","volume":"114","author":"Kim","year":"2011","journal-title":"Anesthesiology"},{"key":"2022062300073919800_gfaa297-B178","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000492379","article-title":"Clinical utility of extracorporeal cytokine hemoadsorption therapy: a literature review","volume":"46","author":"Bonavia","year":"2018","journal-title":"Blood Purif"},{"key":"2022062300073919800_gfaa297-B179","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/14397595.2018.1546357","article-title":"IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review","volume":"29","author":"Ogata","year":"2019","journal-title":"Mod Rheumatol"},{"key":"2022062300073919800_gfaa297-B180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/imt-2017-0075","article-title":"A review of sarilumab for the treatment of rheumatoid arthritis","volume":"10","author":"Lee","year":"2018","journal-title":"Immunotherapy"},{"key":"2022062300073919800_gfaa297-B181","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1152\/ajprenal.00467.2010","article-title":"Isoflurane activates intestinal sphingosine kinase to protect against bilateral nephrectomy-induced liver and intestine dysfunction","volume":"300","author":"Kim","year":"2011","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/7\/1218\/44138382\/gfaa297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaa297\/36780465\/gfaa297.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/37\/7\/1218\/44138382\/gfaa297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T20:10:27Z","timestamp":1655928627000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/37\/7\/1218\/6126390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":181,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,2,2]]},"published-print":{"date-parts":[[2022,6,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaa297","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7]]},"published":{"date-parts":[[2021,2,2]]}}}